197 related articles for article (PubMed ID: 38180590)
1. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
[TBL] [Abstract][Full Text] [Related]
3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
4. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
Takeda K; Tsuboko Y; Iwasaki K
Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
[TBL] [Abstract][Full Text] [Related]
6. Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.
Osman M; Busu T; Osman K; Khan SU; Daniels M; Holmes DR; Alkhouli M
JACC Clin Electrophysiol; 2020 May; 6(5):494-506. PubMed ID: 32439033
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
[TBL] [Abstract][Full Text] [Related]
8. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
[TBL] [Abstract][Full Text] [Related]
9. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
10. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
11. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
[TBL] [Abstract][Full Text] [Related]
12. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure.
Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y
J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825
[TBL] [Abstract][Full Text] [Related]
13. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
[TBL] [Abstract][Full Text] [Related]
14. An Updated Meta-Analysis on the Clinical Outcomes of Percutaneous Left Atrial Appendage Closure Versus Direct Oral Anticoagulation in Patients With Atrial Fibrillation.
Jiang H; Koh TH; Vengkat V; Fei G; Ding ZP; Ewe SH; Jappar I; Lim ST; Yap J
Am J Cardiol; 2023 Aug; 200():135-143. PubMed ID: 37321026
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
[TBL] [Abstract][Full Text] [Related]
16. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
[TBL] [Abstract][Full Text] [Related]
17. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
Black-Maier E; Piccini JP; Granger CB
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.
Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH
Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662
[TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation.
Falasconi G; Gaspardone C; Godino C; Gaspardone A; Radinovic A; Pannone L; Leo G; Posteraro GA; Slavich M; Melillo F; Marzi A; D'Angelo G; Limite LR; Frontera A; Brugliera L; Agricola E; Margonato A; Della Bella P; Mazzone P
Panminerva Med; 2023 Jun; 65(2):227-233. PubMed ID: 34664480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
